Standout Papers

Pathogenic mechanisms in HBV- and HCV-... 1994 2026 2004 2015 630
  1. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma (2013)
    Alla Arzumanyan, Helena Reis et al. Nature reviews. Cancer
  2. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. (1994)
    Xin Wei Wang, Kathleen Forrester et al. Proceedings of the National Academy of Sciences
  3. Human Viral Oncogenesis: A Cancer Hallmarks Analysis (2014)
    Enrique A. Mesri, Mark A. Feitelson et al. Cell Host & Microbe

Immediate Impact

17 by Nobel laureates 39 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
2020 Standout
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
2 intermediate papers

Works of Mark A. Feitelson being referenced

Human Viral Oncogenesis: A Cancer Hallmarks Analysis
2014 Standout
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma
2005

Author Peers

Author Last Decade Papers Cites
Mark A. Feitelson 3426 2094 2538 119 6.0k
Hiroyuki Marusawa 2384 1934 2860 158 7.0k
Chau‐Ting Yeh 4268 3978 2176 287 7.8k
Robert Steele 1691 1805 2245 81 4.9k
Curt H. Hagedorn 1659 2175 3338 90 7.1k
Seishi Murakami 2508 1843 2563 95 5.5k
Stefan Kubicka 1293 1824 2358 157 6.3k
Jing‐hsiung James Ou 4257 2595 2862 100 7.4k
Yosef Shaul 3059 1326 5556 142 8.6k
Ratna B. Ray 3921 3488 4577 177 10.3k
Tatsuya Kanto 2430 2547 1823 215 6.7k

All Works

Loading papers...

Rankless by CCL
2026